Published in BMC Bioinformatics on January 18, 2010
Prediction and analysis of protein solubility using a novel scoring card method with dipeptide composition. BMC Bioinformatics (2012) 0.93
A review of machine learning methods to predict the solubility of overexpressed recombinant proteins in Escherichia coli. BMC Bioinformatics (2014) 0.77
EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet (2000) 69.26
Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol (2001) 66.87
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (1988) 52.71
A comparison of methods for multiclass support vector machines. IEEE Trans Neural Netw (2002) 11.73
Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci (1999) 5.43
Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol Rev (1996) 4.93
Recombinant protein expression in Escherichia coli. Curr Opin Biotechnol (1999) 4.59
A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology (N Y) (1993) 4.49
TargetDB: a target registration database for structural genomics projects. Bioinformatics (2004) 4.17
Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol (2005) 3.29
High-level expression of soluble protein in Escherichia coli using a His6-tag and maltose-binding-protein double-affinity fusion system. Protein Expr Purif (1997) 2.15
New fusion protein systems designed to give soluble expression in Escherichia coli. Biotechnol Bioeng (1999) 2.04
High-throughput screening of soluble recombinant proteins. Protein Sci (2002) 1.90
Mining the structural genomics pipeline: identification of protein properties that affect high-throughput experimental analysis. J Mol Biol (2004) 1.57
SPINE: an integrated tracking database and data mining approach for identifying feasible targets in high-throughput structural proteomics. Nucleic Acids Res (2001) 1.52
Predicting the solubility of recombinant proteins in Escherichia coli. Biotechnology (N Y) (1991) 1.47
High-throughput expression of C. elegans proteins. Genome Res (2004) 1.32
Structural proteomics: prospects for high throughput sample preparation. Prog Biophys Mol Biol (2000) 1.28
Protein solubility: sequence based prediction and experimental verification. Bioinformatics (2006) 1.23
Recombinant protein solubility - does more mean better? Nat Biotechnol (2007) 1.21
Understanding the relationship between the primary structure of proteins and its propensity to be soluble on overexpression in Escherichia coli. Protein Sci (2005) 1.18
AutoMotif server: prediction of single residue post-translational modifications in proteins. Bioinformatics (2005) 1.15
Self-cleavage of fusion protein in vivo using TEV protease to yield native protein. Protein Sci (2005) 1.13
Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli. Biotechnol Appl Biochem (2002) 1.10
A support vector machine-based method for predicting the propensity of a protein to be soluble or to form inclusion body on overexpression in Escherichia coli. Bioinformatics (2005) 1.08
Genomic divergence of Escherichia coli strains: evidence for horizontal transfer and variation in mutation rates. Int Microbiol (2005) 0.95
Improving solubility of Shewanella oneidensis MR-1 and Clostridium thermocellum JW-20 proteins expressed into Esherichia coli. J Proteome Res (2005) 0.86
Parallel gene cloning and protein production in multiple expression systems. Biotechnol Prog (2009) 0.82
Overview of BioCreative II gene mention recognition. Genome Biol (2008) 5.67
FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res (2006) 5.60
Overview of BioCreative II gene normalization. Genome Biol (2008) 5.05
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet (2012) 4.62
The gene normalization task in BioCreative III. BMC Bioinformatics (2011) 2.89
Introducing meta-services for biomedical information extraction. Genome Biol (2008) 2.78
Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases. Proc Natl Acad Sci U S A (2007) 2.00
Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease. Chem Biol (2006) 1.63
Description of the transcriptomes of immune response-activated hemocytes from the mosquito vectors Aedes aegypti and Armigeres subalbatus. Infect Immun (2004) 1.62
Crystal structures of undecaprenyl pyrophosphate synthase in complex with magnesium, isopentenyl pyrophosphate, and farnesyl thiopyrophosphate: roles of the metal ion and conserved residues in catalysis. J Biol Chem (2005) 1.62
The silkworm (Bombyx mori) microRNAs and their expressions in multiple developmental stages. PLoS One (2008) 1.48
miRNA arm selection and isomiR distribution in gastric cancer. BMC Genomics (2012) 1.35
Structural and functional analysis of three β-glucosidases from bacterium Clostridium cellulovorans, fungus Trichoderma reesei and termite Neotermes koshunensis. J Struct Biol (2010) 1.33
BIOADI: a machine learning approach to identifying abbreviations and definitions in biological literature. BMC Bioinformatics (2009) 1.29
Epigenetic control of the expression of a primate-specific microRNA cluster in human cancer cells. Epigenetics (2009) 1.29
Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics (2011) 1.29
Mechanism of the maturation process of SARS-CoV 3CL protease. J Biol Chem (2005) 1.27
Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci U S A (2004) 1.25
Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds. J Biol Chem (2009) 1.23
Bioinformatic discovery of microRNA precursors from human ESTs and introns. BMC Genomics (2006) 1.23
DNA binding and degradation by the HNH protein ColE7. Structure (2004) 1.20
Crystal structure of type-III geranylgeranyl pyrophosphate synthase from Saccharomyces cerevisiae and the mechanism of product chain length determination. J Biol Chem (2006) 1.19
Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation. J Med Chem (2008) 1.18
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate. Biochem Biophys Res Commun (2004) 1.16
Catalytic mechanism revealed by the crystal structure of undecaprenyl pyrophosphate synthase in complex with sulfate, magnesium, and triton. J Biol Chem (2003) 1.13
Bayesian classification for data from the same unknown class. IEEE Trans Syst Man Cybern B Cybern (2002) 1.11
Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg Med Chem (2008) 1.10
Substrate binding mode and reaction mechanism of undecaprenyl pyrophosphate synthase deduced from crystallographic studies. Protein Sci (2004) 1.09
Crystal structure of octaprenyl pyrophosphate synthase from hyperthermophilic Thermotoga maritima and mechanism of product chain length determination. J Biol Chem (2003) 1.08
Automatic morphological subtyping reveals new roles of caspases in mitochondrial dynamics. PLoS Comput Biol (2011) 1.08
Discovery and characterization of medaka miRNA genes by next generation sequencing platform. BMC Genomics (2010) 1.07
Identification of homologous microRNAs in 56 animal genomes. Genomics (2010) 1.01
Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated esters. Bioorg Med Chem (2005) 1.00
The zinc ion in the HNH motif of the endonuclease domain of colicin E7 is not required for DNA binding but is essential for DNA hydrolysis. Nucleic Acids Res (2002) 1.00
Structure-based inhibitors exhibit differential activities against Helicobacter pylori and Escherichia coli undecaprenyl pyrophosphate synthases. J Biomed Biotechnol (2008) 0.99
Emerging strengths in Asia Pacific bioinformatics. BMC Bioinformatics (2008) 0.98
Structures, mechanisms and inhibitors of undecaprenyl diphosphate synthase: a cis-prenyltransferase for bacterial peptidoglycan biosynthesis. Bioorg Chem (2011) 0.98
Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas. PLoS One (2011) 0.97
Synthesis and application of a fluorescent substrate analogue to study ligand interactions for undecaprenyl pyrophosphate synthase. J Am Chem Soc (2002) 0.97
Structure of a heterotetrameric geranyl pyrophosphate synthase from mint (Mentha piperita) reveals intersubunit regulation. Plant Cell (2010) 0.96
dbDNV: a resource of duplicated gene nucleotide variants in human genome. Nucleic Acids Res (2010) 0.94
Intracellular beta-tubulin/chaperonin containing TCP1-beta complex serves as a novel chemotherapeutic target against drug-resistant tumors. Cancer Res (2009) 0.93
UMARS: Un-MAppable Reads Solution. BMC Bioinformatics (2011) 0.93
Boosting multiclass learning with repeating codes and weak detectors for protein subcellular localization. Bioinformatics (2007) 0.92
Gene expression-based chemical genomics identifies potential therapeutic drugs in hepatocellular carcinoma. PLoS One (2011) 0.92
Gene selection for sample classifications in microarray experiments. DNA Cell Biol (2004) 0.92
Sequence features involved in the mechanism of 3' splice junction wobbling. BMC Mol Biol (2010) 0.91
Insight into the activation mechanism of Escherichia coli octaprenyl pyrophosphate synthase derived from pre-steady-state kinetic analysis. Biochim Biophys Acta (2002) 0.91
Probing the conformational change of Escherichia coli undecaprenyl pyrophosphate synthase during catalysis using an inhibitor and tryptophan mutants. J Biol Chem (2001) 0.91
DODO: an efficient orthologous genes assignment tool based on domain architectures. Domain based ortholog detection. BMC Bioinformatics (2010) 0.91
Identification of the active conformation and the importance of length of the flexible loop 72-83 in regulating the conformational change of undecaprenyl pyrophosphate synthase. Biochemistry (2003) 0.91
Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3). Evid Based Complement Alternat Med (2005) 0.90
Mutations in the substrate entrance region of β-glucosidase from Trichoderma reesei improve enzyme activity and thermostability. Protein Eng Des Sel (2012) 0.90
One site mutation disrupts dimer formation in human DPP-IV proteins. J Biol Chem (2004) 0.90
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem (2007) 0.89
Homodimeric hexaprenyl pyrophosphate synthase from the thermoacidophilic crenarchaeon Sulfolobus solfataricus displays asymmetric subunit structures. J Bacteriol (2005) 0.89
A ν-support vector regression based approach for predicting imputation quality. BMC Proc (2012) 0.88
Probing electrostatic channeling in protozoal bifunctional thymidylate synthase-dihydrofolate reductase using site-directed mutagenesis. J Biol Chem (2003) 0.88
Interrogation of rabbit miRNAs and their isomiRs. Genomics (2011) 0.88
Mechanism of cis-prenyltransferase reaction probed by substrate analogues. Biochem Biophys Res Commun (2010) 0.88
Construction and characterization of different fusion proteins between cellulases and β-glucosidase to improve glucose production and thermostability. Bioresour Technol (2010) 0.88
Different reaction mechanisms for cis- and trans-prenyltransferases. Biochem Biophys Res Commun (2008) 0.87
Ligand specificities and structural requirements of two Tachypleus plasma lectins for bacterial trapping. Biochem J (2006) 0.87
Purification and characterization of human prolyl dipeptidase DPP8 in Sf9 insect cells. Protein Expr Purif (2004) 0.87
Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease. J Med Chem (2005) 0.87
Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery. Biochem Soc Trans (2011) 0.86
Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors. Bioorg Med Chem (2010) 0.86
Prioritizing disease candidate genes by a gene interconnectedness-based approach. BMC Genomics (2011) 0.86
Substrate and product specificities of cis-type undecaprenyl pyrophosphate synthase. Biochem J (2005) 0.86
A unified framework of overlapping genes: towards the origination and endogenic regulation. Genomics (2012) 0.86
Insights into the mechanism of the antibiotic-synthesizing enzyme MoeO5 from crystal structures of different complexes. Angew Chem Int Ed Engl (2012) 0.86
Individual and common inhibitors of coronavirus and picornavirus main proteases. FEBS Lett (2009) 0.85
Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma. Mol Cell Proteomics (2013) 0.84
Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV. FEBS Lett (2004) 0.84
MetaMirClust: discovery of miRNA cluster patterns using a data-mining approach. Genomics (2012) 0.84
Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease. J Med Chem (2006) 0.84
Designating eukaryotic orthology via processed transcription units. Nucleic Acids Res (2008) 0.84
Gastric cancer: prognostic and diagnostic advances. Expert Rev Mol Med (2002) 0.83
Targeting the XIAP/caspase-7 complex selectively kills caspase-3-deficient malignancies. J Clin Invest (2013) 0.83
The critical roles of polyamines in regulating ColE7 production and restricting ColE7 uptake of the colicin-producing Escherichia coli. J Biol Chem (2006) 0.83
Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors. FEBS Lett (2007) 0.82
Preliminary X-ray diffraction analysis of octaprenyl pyrophosphate synthase crystals from Thermotoga maritima and Escherichia coli. Acta Crystallogr D Biol Crystallogr (2003) 0.82
Parallel gene cloning and protein production in multiple expression systems. Biotechnol Prog (2009) 0.82
A mammalian cell-based reverse two-hybrid system for functional analysis of 3C viral protease of human enterovirus 71. Anal Biochem (2007) 0.82
A molecular ruler for chain elongation catalyzed by octaprenyl pyrophosphate synthase and its structure-based engineering to produce unprecedented long chain trans-prenyl products. Biochemistry (2004) 0.82
Novel small-molecule inhibitors of transmissible gastroenteritis virus. Antimicrob Agents Chemother (2007) 0.82
Structure and inhibition of tuberculosinol synthase and decaprenyl diphosphate synthase from Mycobacterium tuberculosis. J Am Chem Soc (2014) 0.82
Fine-tuning of microRNA-mediated repression of mRNA by splicing-regulated and highly repressive microRNA recognition element. BMC Genomics (2013) 0.81
Analysis of metabolic syndrome components in >15 000 african americans identifies pleiotropic variants: results from the population architecture using genomics and epidemiology study. Circ Cardiovasc Genet (2014) 0.81
Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease. Bioorg Med Chem (2008) 0.81
Fluorescent substrate analog for monitoring chain elongation by undecaprenyl pyrophosphate synthase in real time. Anal Biochem (2011) 0.81
Multi-class clustering and prediction in the analysis of microarray data. Math Biosci (2004) 0.81
Soft tagging of overlapping high confidence gene mention variants for cross-species full-text gene normalization. BMC Bioinformatics (2011) 0.81
Roles of amino acids in the Escherichia coli octaprenyl diphosphate synthase active site probed by structure-guided site-directed mutagenesis. Biochemistry (2012) 0.81